Furosemide‐induced genotoxicity and cytotoxicity in the hepatocytes, but weak genotoxicity in the bone marrow cells of mice

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Fundamental & Clinical Pharmacology

• Publication date

  2012-06-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1111/j.1472-8206.2011.00927.xPMID 21352352
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Update on genotoxicity and carcinogenicity testing of 472 marketed pharmaceuticals.

  2009cited by this paper
• Intervention of astaxanthin against cyclophosphamide-induced oxidative stress and DNA damage: a study in mice.

  2009cited by this paper
• Use of the alkaline comet assay for the detection of transplacental genotoxins in newborn mice.

  2008cited by this paper
• Hipertensión arterial, cardiopatía hipertensiva e insuficiencia cardíaca. Papel de los diuréticos de asa

  2008cited by this paper
• Cytotoxic and genotoxic effects of methotrexate in germ cells of male Swiss mice.

  2008cited by this paper
• Investigation of the effect of a panel of model hepatotoxins on the Nrf2-Keap1 defence response pathway in CD-1 mice.

  2008cited by this paper
• [Hypertension, hypertensive heart disease and heart failure. Role of loop diuretics].

  2008cited by this paper
• The Metabolism and Toxicity of Furosemide in the Wistar Rat and CD-1 Mouse: a Chemical and Biochemical Definition of the Toxicophore

  2007cited by this paper
• Formation of cytotoxic protein reactive metabolites from furosemide: Biological consequences of drug metabolism

  2007cited by this paper
• Fourth International Workgroup on Genotoxicity testing: results of the in vivo Comet assay workgroup.

  2007cited by this paper
• A multispecies study to assess the toxic and genotoxic effect of pharmaceuticals: furosemide and its photoproduct.

  2006cited by this paper
• Toxicophores: investigations in drug safety.

  2006cited by this paper
• Selection of new chemical entities with decreased potential for adverse drug reactions.

  2006cited by this paper
• Furosemide reverses multidrug resistance status in bladder cancer cells in vitro

  2006cited by this paper
• Genotoxicity and carcinogenicity studies of antihypertensive agents.

  2006cited by this paper
• Yeast DEL assay detects clastogens.

  2005cited by this paper
• Identification of the pharmaceuticals for human use contaminating the Italian aquatic environment.

  2005cited by this paper
• Environmental risk assessment of medicinal products for human use according to European Commission recommendations

  2004cited by this paper
• The role of oxidative stress in carcinogenesis.

  2004cited by this paper
• Essentials of Medical Pharmacology

  2004cited by this paper
• A cross-platform public domain PC image-analysis program for the comet assay.

  2003cited by this paper
• In vivo and in vitro antioxidant properties of furosemide.

  2003cited by this paper
• Effects of hepatotoxic doses of acetaminophen and furosemide on tissue concentrations of CoASH and CoASSG in vivo.

  2000cited by this paper
• The role of mitochondrial injury in bromobenzene and furosemide induced hepatotoxicity.

  2000cited by this paper
• Immunosuppressive and cytotoxic effects of furosemide on human peripheral blood mononuclear cells.

  1999cited by this paper
• Chromosome aberration assays in Pisum for the study of environmental mutagens.

  1998cited by this paper
• The antioxidative properties of furosemide in renal ischemia

  1996cited by this paper
• [The antioxidative properties of furosemide in renal ischemia].

  1996cited by this paper
• Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation

  1992cited by this paper
• Ototoxicity of furosemide during development

  1991cited by this paper
• Toxicology and carcinogenicity studies of diuretics in F344 rats and B6C3F1 mice 2. Furosemide

  1990cited by this paper
• Toxicology and Carcinogenesis Studies of Furosemide (CAS No. 54-31-9) in F344/N Rats and B6C3F1 Mice (Feed Studies).

  1989cited by this paper
• Mammalian in vivo cytogenetic assays. Analysis of chromosome aberrations in bone marrow cells.

  1987cited by this paper
• Food intake measurement: problems and approaches.

  1983cited by this paper
• Furosemide induced hepatotoxicity

  1981cited by this paper
• Clastogenic effects of frusemide on human leukocytes in culture.

  1979cited by this paper
• The role of biliary excretion in the hepatotoxicity of furosemide in the mouse.

  1977cited by this paper
• Metabolic activation of furosemide to a chemically reactive, hepatotoxic metabolite.

  1976cited by this paper
• Ein neuer host mediated assay (Urinversuch) zum Nachweis mutagener Stoffe mitSaccharomyces cerevisiae

  1971cited by this paper
• [A new host mediated assay (urine assay) for the determination of mutagenic drugs using Saccharomyces cerevisiae].

  1971cited by this paper
• Ototoxicity of furosemide.

  1970cited by this paper
• Ototoxicity of furosemide.

  1970cited by this paper
• Ototoxicity of furosemide.

  1970cited by this paper
• Ototoxicity of furosemide.

  1970cited by this paper
• A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid.

  1956cited by this paper

• Direct Photolysis Determines the Environmental Fate of Furosemide and Its Metabolite Saluamine in Sunlit Surface Waters

  2025cites this paper
• Cytogenotoxic Evaluation of Lercanidipine Hydrochloride in Human Lymphocytes Using Micronucleus, Chromosome Abnormalities, and Molecular Docking Assays

  2025cites this paper
• Comprehensive analysis of a widely pharmaceutical, furosemide, and its degradation products in aquatic systems: Occurrence, fate, and ecotoxicity.

  2024cites this paper
• Degradation of cardiovascular drug furosemide in aqueous by electron beam irradiation: Mechanisms, degradation pathways and toxicity assessment

  2024cites this paper
• Genotoxicity of Psychotropic Drugs in Experimental and Clinical Studies

  2023cites this paper
• In silico environmental risk assessment of fate and effects of pharmaceuticals and their TPs generated and treated by coupling tertiary processes in hospital wastewater

  2023cites this paper
• Assessment of the genotoxic effects of antihypertensive drug active ingredient indapamide in human lymphocytes

  2022cites this paper
• Genetic toxicity assessment using liver cell models: past, present, and future

  2019cites this paper
• The third‐generation retinoid adapalene triggered DNA damage to induce S‐phase arrest in HaCat cells

  2019cites this paper
• Sensitivity and specificity prediction of the buccal micronucleus cytome assay in end-stage renal disease patients on dialysis: A case-control study.

  2017cites this paper
• Microbial biotransformation of furosemide for environmental risk assessment: identification of metabolites and toxicological evaluation

  2016cites this paper
• Use of Loop Diuretics is Associated with Increased Mortality in Patients with Suspected Coronary Artery Disease, but without Systolic Heart Failure or Renal Impairment: An Observational Study Using Propensity Score Matching

  2015cites this paper
• Micronuclei and nuclear abnormalities in buccal mucosa cells in patients with anorexia and bulimia nervosa.

  2014cites this paper
• Erythromycin‐induced genotoxicity and hepatotoxicity in mice pups treated during prenatal and postnatal period

  2014cites this paper
• Anticipating the fate and impact of organic environmental contaminants: a new approach applied to the pharmaceutical furosemide.

  2014cites this paper
• 3-Aminobenzamide – a PARP inhibitor enhances the sensitivity of peripheral blood micronucleus and comet assays in mice

  2014cites this paper
• Original article: DNA AND CHROMOSOMAL DAMAGE IN CORONARY ARTERY DISEASE PATIENTS

  2013cites this paper
• DNA and chromosomal damage in coronary artery disease patients

  2013cites this paper